FDA Inspection 1058402 — Lanzhou Foci Pharmaceutical Co., Ltd.

Lanzhou Foci Pharmaceutical Co., Ltd. — FEI 3004252872

The FDA completed an inspection of Lanzhou Foci Pharmaceutical Co., Ltd. on Jul 5, 2018 in Lanzhou. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Jul 5, 2018
Fiscal Year
2018
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Lanzhou (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.